<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1493</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7643854</PubmedId>
            <Abstract>Relative affinities were determined for the interaction of H-2Db with all the peptides from the A/PR/8/34 strain of influenza virus that contained the Db-binding motif. The results indicated that, even though 23 peptides with the appropriate motif were identified and analysed, binding of only five of them could be detected at peptide concentrations lower than 10(-7) M. Of these five, only one, TGICNQNII, bound with better affinity than the nucleoprotein-derived natural epitope, ASNENMETM. The origin of the higher binding peptide was the influenza neuraminidase, a protein for which little cytosolic processing would be expected since it is a surface glycoprotein. To establish why many of the influenza-derived peptides did not bind, the role of non-anchor residues on Db-peptide interactions was analysed, using a scheme where QDIENEEKI, a non-binding peptide from the influenza virus polymerase 1, was sequentially converted to ASNENMETI, which binds to Db with an affinity similar to that of ASNENMETM. Although all positions examined influenced peptide binding, peptide residue no. 2 (P2) was of particular importance. Therefore, each of the 20 naturally occurring amino acids were inserted at this position to investigate their effects on peptide-MHC interaction. The results indicated that amino acids having side chains with charged or ring structures were deleterious, while non-polar and polar residues were either neutral or facilitated binding to different degrees. Our data also indicated that every residue of the peptide contributes to the stability of the MHC-peptide complex, and the final affinity is dependent on the nature of the amino acids at each position, not just on those at a small number of anchor positions. The results also suggested that increased stability, as indicated by the half-life of the peptide-MHC class I complex, might play an important role in selecting the immunodominant epitope.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>623-32</ArticlePages>
            <ArticleTitle>Db-binding peptides from influenza virus: effect of non-anchor residues on stability and immunodominance.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Sigal</LastName>
                    <ForeName>L J</ForeName>
                </Author>
                <Author>
                    <LastName>Goebel</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Wylie</LastName>
                    <ForeName>D E</ForeName>
                </Author>
            </Authors>
            <Affiliations>School of Biological Sciences, University of Nebraska, Lincoln 68588, USA.</Affiliations>
            <ArticleChemicalList>Antigens, Viral;H-2 Antigens;Peptides</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens, Viral(immunology; metabolism); Epitope Mapping; H-2 Antigens(immunology; metabolism); Influenza A virus(immunology); Mice; Molecular Sequence Data; Peptides(immunology); Protein Binding; Structure-Activity Relationship</ArticleMeshHeadingsList>
            <Journal>
                <Volume>32</Volume>
                <Issue>9</Issue>
                <Title>Molecular immunology</Title>
                <Issn>0161-5890</Issn>
                <MedlineTa>Mol Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HA 258-266</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IFEANGNLI</LinearSequence>
                        <StartingPosition>258</StartingPosition>
                        <EndingPosition>266</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC133</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>26048</EpitopeId>
                <ReferenceStartingPosition>258</ReferenceStartingPosition>
                <ReferenceEndingPosition>266</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003303</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 333-341</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGLRNIPSI</LinearSequence>
                        <StartingPosition>333</StartingPosition>
                        <EndingPosition>341</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC133</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>63886</EpitopeId>
                <ReferenceStartingPosition>333</ReferenceStartingPosition>
                <ReferenceEndingPosition>341</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003304</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>80.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HA 469-477</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QLKNNAKEI</LinearSequence>
                        <StartingPosition>469</StartingPosition>
                        <EndingPosition>477</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC133</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>51394</EpitopeId>
                <ReferenceStartingPosition>469</ReferenceStartingPosition>
                <ReferenceEndingPosition>477</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003305</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>M2 27-35</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AIAANIIGI</LinearSequence>
                        <StartingPosition>27</StartingPosition>
                        <EndingPosition>35</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P06821.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>1838</EpitopeId>
                <ReferenceStartingPosition>27</ReferenceStartingPosition>
                <ReferenceEndingPosition>35</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M). For this epitope, the sequence in Table 1 is AIRANIIGI --- however, the source specified by the author lists the sequence as AIAANIIGI. Thus, it seems that there was a typographical error since no source matches the previous sequence exactly in a BLAST search.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003307</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NA 24-32</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LQIGNIISI</LinearSequence>
                        <StartingPosition>24</StartingPosition>
                        <EndingPosition>32</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03468.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>38852</EpitopeId>
                <ReferenceStartingPosition>24</ReferenceStartingPosition>
                <ReferenceEndingPosition>32</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003308</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>110.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NA 40-48</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGSQNHTGI</LinearSequence>
                        <StartingPosition>40</StartingPosition>
                        <EndingPosition>48</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03468.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>63968</EpitopeId>
                <ReferenceStartingPosition>40</ReferenceStartingPosition>
                <ReferenceEndingPosition>48</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003318</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NA 46-54</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGICNQNII</LinearSequence>
                        <StartingPosition>46</StartingPosition>
                        <EndingPosition>54</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03468.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>63853</EpitopeId>
                <ReferenceStartingPosition>46</ReferenceStartingPosition>
                <ReferenceEndingPosition>54</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003319</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.8</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NA 85-93</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YSKDNSIRI</LinearSequence>
                        <StartingPosition>85</StartingPosition>
                        <EndingPosition>93</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03468.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>75775</EpitopeId>
                <ReferenceStartingPosition>85</ReferenceStartingPosition>
                <ReferenceEndingPosition>93</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003320</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>700.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NA 336-344</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YRYGNGVWI</LinearSequence>
                        <StartingPosition>336</StartingPosition>
                        <EndingPosition>344</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03468.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>75688</EpitopeId>
                <ReferenceStartingPosition>336</ReferenceStartingPosition>
                <ReferenceEndingPosition>344</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003322</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP 17-25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GERQNATEI</LinearSequence>
                        <StartingPosition>17</StartingPosition>
                        <EndingPosition>25</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>19421</EpitopeId>
                <ReferenceStartingPosition>17</ReferenceStartingPosition>
                <ReferenceEndingPosition>25</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003323</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP 55-63</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLIQNSLTI</LinearSequence>
                        <StartingPosition>55</StartingPosition>
                        <EndingPosition>63</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>54593</EpitopeId>
                <ReferenceStartingPosition>55</ReferenceStartingPosition>
                <ReferenceEndingPosition>63</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003324</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>70.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP 97-105</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YRRVNGKWM</LinearSequence>
                        <StartingPosition>97</StartingPosition>
                        <EndingPosition>105</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>75671</EpitopeId>
                <ReferenceStartingPosition>97</ReferenceStartingPosition>
                <ReferenceEndingPosition>105</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003325</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NP 366-374</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASNENMETM</LinearSequence>
                        <StartingPosition>366</StartingPosition>
                        <EndingPosition>374</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC124</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>4602</EpitopeId>
                <ReferenceStartingPosition>366</ReferenceStartingPosition>
                <ReferenceEndingPosition>374</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003326</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding". The RA value for NP 366-374 was 8.0 for one experiment (Table 1) and 9.0 for another experiment (Table 3).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>NS 129-137</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILKANFSVI</LinearSequence>
                        <StartingPosition>129</StartingPosition>
                        <EndingPosition>137</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03496.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>27119</EpitopeId>
                <ReferenceStartingPosition>129</ReferenceStartingPosition>
                <ReferenceEndingPosition>137</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003327</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>80.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 1 331-339</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EWFRNVLSL</LinearSequence>
                        <StartingPosition>331</StartingPosition>
                        <EndingPosition>339</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA43637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>14933</EpitopeId>
                <ReferenceStartingPosition>331</ReferenceStartingPosition>
                <ReferenceEndingPosition>339</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M). This sequence is derived from a generic influenza A virus source; the sequence for the A/Puerto Rico/8/34 strain is EWFRNVLSI.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003328</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 1 451-459</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VNAPNHEGI</LinearSequence>
                        <StartingPosition>451</StartingPosition>
                        <EndingPosition>459</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03431.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>70049</EpitopeId>
                <ReferenceStartingPosition>451</ReferenceStartingPosition>
                <ReferenceEndingPosition>459</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003330</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 1 593-601</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DGGPNLYNI</LinearSequence>
                        <StartingPosition>593</StartingPosition>
                        <EndingPosition>601</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03431.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>8394</EpitopeId>
                <ReferenceStartingPosition>593</ReferenceStartingPosition>
                <ReferenceEndingPosition>601</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003331</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 1 637-645</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IESMNNAVM</LinearSequence>
                        <StartingPosition>637</StartingPosition>
                        <EndingPosition>645</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03431.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>25974</EpitopeId>
                <ReferenceStartingPosition>637</ReferenceStartingPosition>
                <ReferenceEndingPosition>645</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003332</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 1 638-646</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ESMNNAVMM</LinearSequence>
                        <StartingPosition>638</StartingPosition>
                        <EndingPosition>646</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03431.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>14216</EpitopeId>
                <ReferenceStartingPosition>638</ReferenceStartingPosition>
                <ReferenceEndingPosition>646</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003333</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 2 346-354</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QDIENEEKI</LinearSequence>
                        <StartingPosition>346</StartingPosition>
                        <EndingPosition>354</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC121</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>50471</EpitopeId>
                <ReferenceStartingPosition>346</ReferenceStartingPosition>
                <ReferenceEndingPosition>354</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003334</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 2 515-523</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TDVVNFVSM</LinearSequence>
                        <StartingPosition>515</StartingPosition>
                        <EndingPosition>523</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC121</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>63271</EpitopeId>
                <ReferenceStartingPosition>515</ReferenceStartingPosition>
                <ReferenceEndingPosition>523</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003335</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 3 133-141</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VHFRNQVKI</LinearSequence>
                        <StartingPosition>133</StartingPosition>
                        <EndingPosition>141</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC121</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>68849</EpitopeId>
                <ReferenceStartingPosition>133</ReferenceStartingPosition>
                <ReferenceEndingPosition>141</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003336</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>400.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>POL 3 452-460</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPIDNVMGM</LinearSequence>
                        <StartingPosition>452</StartingPosition>
                        <EndingPosition>460</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC121</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>211044</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>13663</EpitopeId>
                <ReferenceStartingPosition>452</ReferenceStartingPosition>
                <ReferenceEndingPosition>460</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope predicted based on the H-2 I Db binding motif XXXXNXXX(I,M).</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>1003354</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to  H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db.  A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASNENMETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASNENMETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4599</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the H-2 Db-binding NP 366-374 epitope with I substituted for M at residue 9 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1003355</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>8.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding". The RA value for the ASNENMETI peptide was 8.0  for one experiment (Table 2) and 4.0 for another experiment (Table 3).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ADIENEEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ADIENEEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>680</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with A substituted for Q at residue 1 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1003357</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSIENEEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSIENEEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52338</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2 and Table 3</LocationOfData>
                        <MhcBindingId>1003358</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>70.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 nM was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 nM to be "high binding". The RA value for this peptide was 70 in one experiment (Table 2) and 90 in another experiment (Table 3).</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QDNENEEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QDNENEEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>50496</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with N substituted for I at residue 3 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1003359</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QDIENMEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QDIENMEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>50473</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with M substituted for E at residue 6 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1003360</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QDIENMETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QDIENMETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>50474</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with M substituted for E at residue 6 and T substituted for K at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1003361</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSNENEEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSNENEEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52382</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2 and N substituted for I at residue 3 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003362</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>200.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSIENMEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSIENMEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52340</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2 and M substituted for E at residue 6 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003363</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSIENEETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSIENEETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52339</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2 and T substituted for K at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003366</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSNENMEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSNENMEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52384</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2, N subsituted for I at residue 3, and M substituted for E at residue 6 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003367</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>100.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSNENEETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSNENEETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52383</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2, N subsituted for I at residue 3, and T substituted for K at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003376</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>21.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSIENMETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSIENMETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52341</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with S substituted for D at residue 2, M subsituted for E at residue 6, and T substituted for K at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003377</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.4</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSNENMETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSNENMETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52385</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with Q substituted for A at residue 1and I subsituted for M at residue 9 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003378</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52386</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with Q substituted for A at residue 1 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003380</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>QSIENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>QSIENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>52342</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with Q substituted for A at residue 1 and I substituted for N at residue 3 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003382</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENEEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENEEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4472</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with A substituted for Q at residue 1 and S substituted for D at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003383</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>20.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASNENEEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASNENEEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4567</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with A substituted for Q at residue 1, S substituted for D at residue 2, and N substituted for I at residue 3 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003385</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>70.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENMEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENMEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4475</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with A substituted for Q at residue 1, S substituted for D at residue 2, and M substituted for E at residue 6 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003387</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENEETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENEETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>QDIENEEKI</LinearSequence>
                            <StartingPosition>346</StartingPosition>
                            <EndingPosition>354</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC121</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4473</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the POL 2 346-354 peptide QDIENEEKI with A substituted for Q at residue 1, S substituted for D at residue 2, and T substituted for K at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003388</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.3</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASNENMEKI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASNENMEKI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4589</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with  K substituted for T at residue 8 and I substituted for M at residue 9 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003389</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>10.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASNENEETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASNENEETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4568</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with  E substituted for M at residue 6 and I substituted for M at residue 9 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003390</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>5.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENMETI</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENMETI</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4477</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with  I substituted for N at residue 3 and I substituted for M at residue 9 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003393</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4478</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with  I substituted for N at residue 3 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 3</LocationOfData>
                        <MhcBindingId>1003394</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.1</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENEETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENEETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4474</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with  I substituted for N at residue 3 and E substituted for M at residue 6 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>1003395</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>6.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASNENMEKM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASNENMEKM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4590</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with  K substituted for T at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>1003401</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>18.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ASIENMEKM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ASIENMEKM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4476</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with I substituted for N at residue 3 and  K substituted for T at residue 8 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 6</LocationOfData>
                        <MhcBindingId>1003402</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AANENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AANENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>318</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with A substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003403</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>5.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ACNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ACNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>580</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with C substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003404</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>100.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ADNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ADNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>733</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with D substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003405</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>700.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AENENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AENENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>1092</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with E substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003406</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AFNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AFNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>1361</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with F substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003407</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AGNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AGNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>1619</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with G substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003408</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>10.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AHNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AHNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>1803</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with H substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003409</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>80.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AKNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AKNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>2249</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with K substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003410</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>220.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ALNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ALNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>2778</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with L substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003411</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>80.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AMNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AMNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>3161</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with M substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003412</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.4</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ANNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ANNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>3356</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with N substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003413</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>APNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>APNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>3662</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with P substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003414</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AQNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AQNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4012</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with Q substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003415</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ARNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ARNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>4200</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with R substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003416</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AVNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AVNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>5482</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with V substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003417</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AWNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AWNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>5681</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with W substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003418</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>4000.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AYNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AYNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>5881</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with Y substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1003419</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>700.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AINENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>AINENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>2031</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with I substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1008456</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>10.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ATNENMETM</EpitopeName>
                <EpitopeStructure>
                    <SequenceMoleculeNoNaturalSource>
                        <ChemicalType>Peptide, no natural source</ChemicalType>
                        <LinearSequence>ATNENMETM</LinearSequence>
                    </SequenceMoleculeNoNaturalSource>
                </EpitopeStructure>
                <EpitopeRelatedObject>
                    <RelatedObjectType>The epitope is an analog of:</RelatedObjectType>
                    <RelatedObject>
                        <FragmentOfANaturalSequenceMolecule>
                            <ChemicalType>Peptide from protein</ChemicalType>
                            <LinearSequence>ASNENMETM</LinearSequence>
                            <StartingPosition>366</StartingPosition>
                            <EndingPosition>374</EndingPosition>
                            <SourceMolecule>
                                <IedbAccession>SRC124</IedbAccession>
                            </SourceMolecule>
                            <SourceOrganismId>211044</SourceOrganismId>
                        </FragmentOfANaturalSequenceMolecule>
                    </RelatedObject>
                </EpitopeRelatedObject>
                <EpitopeId>5062</EpitopeId>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This is an analog of the NP 366-374 peptide ASNENMETM with T substituted for S at residue 2 of the peptide.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 7</LocationOfData>
                        <MhcBindingId>1008457</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>297</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>30.0</QuantitativeMeasurement>
                            <AssayComments>A cell panning enzyme immunoassay (CPEIA) was used, and the relative affinity (RA) was calculated as the concentration of peptide (in nM) that gave 50% of maximum binding to H-2 I Db on RMA-S cells. The "quantitative measurement" field shows the RA of the peptide for H-2 I Db. A lower RA correlates with higher binding. An RA &lt; 10,000 was considered positive in the "qualitative measurement" field. The authors considered an RA &lt; 100 to be "high binding".</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

